Collection register
All documents and their final editions.
Records · 310
- CGR-BP-001 · Aqueous Calamine Cream
- CGR-BP-002 · Aqueous Cream
- CGR-BP-003 · Benzyl Benzoate Application
- CGR-BP-004 · Buffered Cream
- CGR-BP-005 · Calamine and Coal Tar Ointment
- CGR-BP-006 · Calamine Lotion
- CGR-BP-007 · Calamine Ointment
- CGR-BP-008 · Calcium Hydroxide Solution
- CGR-BP-009 · Cetomacrogol Emulsifying Ointment
- CGR-BP-010 · Cetomacrogol Emulsifying Wax
- CGR-BP-011 · Cetrimide Cream 0.5% w/w
- CGR-BP-012 · Compound Zinc Paste
- CGR-BP-013 · Dithranol Ointment
- CGR-BP-014 · Emulsifying Ointment
- CGR-BP-015 · Emulsifying Wax
- CGR-BP-016 · Glycerol Suppositories
- CGR-BP-017 · Hydrous Ointment
- CGR-BP-018 · Magnesium Sulfate Paste
- CGR-BP-019 · Methyl Salicylate Ointment
- CGR-BP-020 · Simple Ointment
- CGR-BP-021 · Sodium Bicarbonate Ear Drops
- CGR-BP-022 · Syrup
- CGR-BP-023 · Wool Alcohols Ointment
- CGR-BP-024 · Zinc and Castor Oil Ointment
- CGR-BP-025 · Zinc and Coal Tar Paste
- CGR-BP-026 · Zinc and Ichthammol Cream
- CGR-BP-027 · Zinc and Salicylic Acid Paste
- CGR-BP-028 · Zinc Cream
- CGR-BP-029 · Zinc Ointment
- CGR-BP-030 · Alcoholic Iodine Solution
- CGR-BP-031 · Aqueous Iodine Oral Solution
- CGR-BP-032 · Aluminium Acetate Ear Drops
- CGR-BP-033 · Flexible Collodion
- CGR-BP-034 · Benzoin Inhalation
- CGR-BP-035 · Compound Benzoin Tincture
- CGR-BP-036 · Peppermint Spirit
- CGR-BE-001 · Diluent A FTM — lactose
- CGR-BE-002 · Diluent B FTM — mannitol
- CGR-BE-003 · Preserved water FTM
- CGR-BE-004 · Buffered cetomacrogol cream FTM
- CGR-BE-005 · Carbomer 980 gel FTM
- CGR-BE-006 · Hydrated sorbitan sesquioleate petrolatum FTM
- CGR-BE-007 · MCC/carmellose dispersion FTM
- CGR-BE-008 · Permethrin cream 5% w/w FTM
- CGR-BE-009 · Hydrocortisone acetate cream 1% FTM
- CGR-BE-010 · Urea lipophilic cream 10% FTM
- CGR-BE-011 · Urea hydrophilic cream 10% FTM
- CGR-BE-012 · Metronidazole gel 1% FTM
- CGR-BE-013 · Minoxidil cutaneous solution 2% w/w FTM
- CGR-BE-014 · Spironolactone capsules 25 mg FTM
- CGR-BE-015 · Omeprazole oral suspension 2 mg/g FTM
- CGR-BE-016 · Paracetamol capsules 250–500 mg FTM
- CGR-BE-017 · Macrocrystalline nitrofurantoin oral suspension 6 mg/mL FTM
- CGR-BE-018 · Trimethoprim oral suspension 10 mg/mL FTM
- CGR-BE-019 · Riboflavin capsules 400 mg FTM
- CGR-BE-020 · Miconazole base oral gel 2% FTM
- CGR-FR-001 · Iodine alcoholic solution 1% Ph. Fr.
- CGR-FR-002 · Cosmetic cerate Ph. Fr.
- CGR-FR-003 · Galen cerate Ph. Fr.
- CGR-FR-004 · Modified Galen cerate Ph. Fr.
- CGR-FR-005 · Glycerinated cerate Ph. Fr.
- CGR-FR-006 · Collodion Ph. Fr.
- CGR-FR-007 · Therapeutic placebo tablets Ph. Fr.
- CGR-FR-008 · Oleo-calcareous cream Ph. Fr.
- CGR-FR-009 · Carmine capsules 200–500 mg Ph. Fr.
- CGR-FR-010 · Nadolol capsules 1–50 mg Ph. Fr.
- CGR-FR-011 · Starch glycerolate Ph. Fr.
- CGR-FR-012 · Zinc oxide starch glycerolate Ph. Fr.
- CGR-FR-013 · Therapeutic placebo capsules Ph. Fr.
- CGR-FR-014 · Spironolactone capsules 0.5–25 mg Ph. Fr.
- CGR-FR-015 · Sodium chloride capsules 50 mg–1 g Ph. Fr.
- CGR-FR-016 · Amiodarone hydrochloride capsules 5–200 mg Ph. Fr.
- CGR-FR-017 · Sodium bicarbonate capsules Ph. Fr.
- CGR-FR-018 · Oleo-calcareous liniment Ph. Fr.
- CGR-FR-019 · Salicylic acid ointment 1–50% Ph. Fr.
- CGR-FR-020 · Zinc oxide paste, Lassar, Ph. Fr.
- CGR-FR-021 · Acacia oral vehicle (potion gommeuse) Ph. Fr.
- CGR-FR-022 · Copper and zinc ointment, camphor-free Dalibour
- CGR-FR-023 · Camphor ointment 10% or 20% Ph. Fr.
- CGR-FR-024 · Zinc oxide ointment 10% Ph. Fr.
- CGR-FR-025 · Aqueous zinc paste, Darier, Ph. Fr.
- CGR-FR-026 · Therapeutic placebo syrup Ph. Fr.
- CGR-FR-027 · Simple syrup Ph. Fr.
- CGR-FR-028 · Glycerol oral solution 0.644 g/mL Ph. Fr.
- CGR-ES-001 · Beeler cream base AEMPS
- CGR-ES-002 · Preserved water without propylene glycol AEMPS
- CGR-ES-003 · AEMPS preserved syrup — nominal 84% w/v
- CGR-ES-004 · Sodium carmellose oral gel 1% AEMPS
- CGR-ES-005 · Metronidazole gel 1% AEMPS
- CGR-ES-006 · Hydrochlorothiazide oral suspension 2 mg/mL AEMPS
- CGR-ES-007 · Captopril oral solution 1 mg/mL AEMPS
- CGR-ES-008 · Furosemide oral solution 2 mg/mL AEMPS
- CGR-ES-009 · Enalapril maleate oral solution 1 mg/mL AEMPS
- CGR-ES-010 · Amlodipine 0.5 mg/mL oral solution
- CGR-ES-011 · Hydrocortisone oral suspension 1 mg/mL AEMPS
- CGR-ES-012 · Gabapentin oral solution 50 mg/mL AEMPS
- CGR-ES-013 · Sodium citrate/citric acid oral solution AEMPS
- CGR-ES-014 · Artificial saliva AEMPS
- CGR-ES-015 · Urea cream 15% AEMPS
- CGR-ES-016 · Minoxidil cutaneous solution 2% w/w AEMPS
- CGR-BP-037 · Cetrimide Emulsifying Ointment
- CGR-BP-038 · Chloroxylenol Solution
- CGR-BP-039 · Coal Tar Solution
- CGR-BP-040 · Strong Coal Tar Solution
- CGR-BP-041 · Compound Benzoic Acid Ointment
- CGR-BP-042 · Compound Aluminium Paste
- CGR-BP-043 · Compound Glucose Sodium Chloride and Sodium Citrate Oral Solution
- CGR-BP-044 · Soap Spirit
- CGR-BP-045 · Concentrated Anise Water
- CGR-BP-046 · Concentrated Camphor Water
- CGR-BP-047 · Concentrated Cinnamon Water
- CGR-BP-048 · Benzoic Acid Solution
- CGR-BE-021 · Buffered Cetomacrogol Emulsion FTM
- CGR-BE-022 · Anionic Hydrophilic Cream FTM
- CGR-BE-023 · Econazole Nitrate Cream 1% w/w
- CGR-BE-024 · Miconazole Nitrate Cream 2% w/w
- CGR-BE-025 · Miconazole Nitrate Emulsion 2% w/w
- CGR-BE-026 · Crotamiton Cream 10% w/w
- CGR-BE-027 · Crotamiton Emulsion 10% w/w
- CGR-BE-028 · Clindamycin Phosphate Solution 1.5% w/w as Clindamycin
- CGR-BE-029 · Erythromycin Gel 2% or 4% w/w
- CGR-BE-030 · Erythromycin Hydroalcoholic Solution 4% w/w
- CGR-BE-031 · Acetazolamide Capsules 250 mg
- CGR-BE-032 · Hydrocortisone Capsules 10 or 20 mg
- CGR-BE-033 · Cetirizine Dihydrochloride Capsules 10 mg
- CGR-BE-034 · Diosmin Capsules 500 mg
- CGR-BE-035 · Loperamide Hydrochloride Capsules 2 mg
- CGR-BE-036 · Aciclovir Oral Suspension 400 mg/5 mL
- CGR-BE-037 · Metronidazole Benzoate Suspension 200 mg/5 mL as Metronidazole
- CGR-BE-038 · Ibuprofen Gel 5% w/w
- CGR-BE-039 · Aluminium Chloride Hexahydrate Solution 15% w/w
- CGR-BE-040 · Hydrogen Peroxide Ear Solution 3% w/w
- CGR-ES-017 · Hydroxybenzoate Concentrate EX025
- CGR-ES-018 · Preserved Water EX001
- CGR-ES-019 · Nonionic O/W Emulsion 1 EX010
- CGR-ES-020 · Nonionic O/W Emulsion 2 EX011
- CGR-ES-021 · Neutral Carbomer 940 Gel EX020
- CGR-ES-022 · Simple Syrup 84% w/v EX022
- CGR-ES-023 · Aluminium Acetate Solution AEMPS
- CGR-ES-024 · Acetic Acid Ear Drops AEMPS
- CGR-ES-025 · Lidocaine Hydrochloride Anaesthetic Gel 1% w/w
- CGR-ES-026 · Hydrocortisone Cream 0.5% w/w AEMPS
- CGR-ES-027 · Viscous Lidocaine Hydrochloride 0.5% w/w
- CGR-ES-028 · Weak Lugol Solution AEMPS 2025
- CGR-ES-029 · Clonidine Hydrochloride Oral Solution 20 micrograms/mL
- CGR-ES-030 · Isoniazid Oral Solution 50 mg/mL
- CGR-ES-031 · Ethambutol Hydrochloride Oral Solution 50 mg/mL
- CGR-ES-032 · Pyridoxine Hydrochloride Oral Solution 25 mg/mL
- CGR-ES-033 · Dexamethasone Oral Solution 1 mg/mL
- CGR-ES-034 · Hydralazine Hydrochloride Oral Solution 10 mg/mL
- CGR-ES-035 · Folic Acid Oral Solution 1 mg/mL
- CGR-ES-036 · Thiamine Hydrochloride Oral Solution 100 mg/mL
- CGR-ES-037 · Riboflavin Oral Solution 25 mg/mL
- CGR-ES-038 · Aqueous Chlorhexidine Digluconate Solution 0.1% AEMPS
- CGR-ES-039 · Disodium Eosin Aqueous Solution 2% w/v
- CGR-ES-040 · Zinc Sulfate Heptahydrate Solution 0.1% w/v
- CGR-JP-001 · Absorptive Cream JP
- CGR-JP-002 · Hydrophilic Cream JP
- CGR-JP-003 · Macrogol Ointment JP
- CGR-JP-004 · Hydrophilic Petrolatum JP
- CGR-US-001 · Acetazolamide 25 mg/mL oral suspension
- CGR-US-002 · Allopurinol 20 mg/mL oral suspension
- CGR-US-003 · Amiodarone 5 mg/mL oral suspension
- CGR-US-004 · Atenolol 2 mg/mL oral solution
- CGR-US-005 · Bethanechol 5 mg/mL oral suspension
- CGR-US-006 · Carvedilol 0.5 mg/mL oral suspension
- CGR-US-007 · Celecoxib 10 mg/mL oral suspension
- CGR-US-008 · Cinacalcet 5 mg/mL oral suspension
- CGR-US-009 · Lamotrigine 1 mg/mL oral suspension
- CGR-US-010 · Nifedipine 4 mg/mL oral suspension
- CGR-US-011 · Quinidine sulfate 10 mg/mL oral suspension
- CGR-US-012 · Rifabutin 20 mg/mL oral suspension
- CGR-US-013 · Tinidazole 66.7 mg/mL oral suspension
- CGR-US-014 · Verapamil 50 mg/mL oral suspension
- CGR-CA-001 · Baclofen 10 mg/mL oral suspension
- CGR-CA-002 · Clobazam 1 mg/mL oral suspension
- CGR-CA-003 · Diazoxide 10 mg/mL oral suspension
- CGR-CA-004 · Domperidone 1 mg/mL oral suspension
- CGR-CA-005 · Glycopyrrolate 0.5 mg/mL oral suspension
- CGR-CA-006 · Lisinopril 1 mg/mL oral suspension
- CGR-CA-007 · Prednisone 5 mg/mL oral suspension
- CGR-NZ-001 · Melatonin 1 mg/mL oral suspension
- CGR-NZ-002 · Carvedilol 1 mg/mL oral suspension
- CGR-NZ-003 · Sotalol hydrochloride 5 mg/mL oral suspension
- CGR-NZ-004 · Terbinafine 25 mg/mL oral suspension
- CGR-NZ-005 · Dipyridamole 10 mg/mL oral suspension
- CGR-NZ-006 · Flecainide acetate 20 mg/mL oral suspension
- CGR-NZ-007 · Phenobarbital sodium 10 mg/mL oral solution
- CGR-BR-001 · Paraben concentrate 6% + 3% w/w
- CGR-BR-002 · Citric acid 25–50% w/v auxiliary solution
- CGR-BR-003 · Imidazolidinyl urea 50% w/v preservative solution
- CGR-BR-004 · Triethanolamine 50% w/v auxiliary solution
- CGR-BR-005 · High-viscosity hydroxyethylcellulose gel
- CGR-BR-006 · Fluid hydroxyethylcellulose gel
- CGR-BR-007 · Nonionic lotion base I — FNFB
- CGR-BR-008 · Vanishing cream — FNFB
- CGR-BR-009 · Anionic cream I — FNFB
- CGR-BR-010 · Sodium chloride 25% w/v thickening intermediate
- CGR-BR-011 · Sodium fluoride 0.05% w/v mouth rinse
- CGR-BR-012 · Chlorhexidine digluconate 0.1% w/v mouth rinse
- CGR-BR-013 · Aluminium hydroxide 6% w/v suspension
- CGR-BR-014 · Aluminium hydroxide 6% and magnesium hydroxide 4% w/v suspension
- CGR-BR-015 · Lidocaine hydrochloride 2% w/v oromucosal topical solution
- CGR-BR-016 · Simple syrup 85% w/v — FNFB
- CGR-FR-029 · Amoxicillin 125 / 250 / 500 mg capsules from bulk API
- CGR-FR-030 · Aprepitant 20 mg/mL from 80 mg capsules
- CGR-FR-031 · Clarithromycin 250 / 500 mg capsules
- CGR-FR-032 · Flucytosine 50 mg/mL oral suspension
- CGR-FR-033 · Sertraline 25 / 50 mg capsules
- CGR-FR-034 · Quetiapine 50 / 100 / 150 mg immediate-release capsules
- CGR-ES-041 · Firm hydrophilic cream 1 EX003
- CGR-ES-042 · Firm hydrophilic cream 2 EX004
- CGR-ES-043 · Anionic O/W emulsion EX007
- CGR-ES-044 · Fluid nonionic O/W emulsion EX009
- CGR-ES-045 · Nonionic O/W emulsion 3 EX012
- CGR-ES-046 · W/O emulsion EX005 Cold cream
- CGR-ES-047 · Water-in-silicone emulsion EX006
- CGR-ES-048 · Fluid anionic O/W emulsion EX008
- CGR-ES-049 · Capsule diluent 1 EX013
- CGR-ES-050 · Capsule diluent 2 EX014
- CGR-ES-051 · Oral adhesive gel EX015
- CGR-ES-052 · Carmellose sodium gel 2% EX016
- CGR-ES-053 · Methylcellulose gel 4% EX017
- CGR-ES-054 · Fluid methylcellulose gel 1% EX018
- CGR-ES-055 · Hydroalcoholic methylcellulose gel EX019
- CGR-ES-056 · Neutral hydroalcoholic carbomer gel EX021
- CGR-ES-057 · Bentonite magma 5% EX023
- CGR-ES-058 · Hydroalcoholic vehicle 1 EX026
- CGR-ES-059 · Hydroalcoholic vehicle 2 EX027
- CGR-ES-060 · Camphorated oil 10% PO001
- CGR-ES-061 · Salicylic oil 5% with ethanol PO003
- CGR-ES-062 · Salicylic oil 5% without ethanol PO004
- CGR-ES-063 · Thymol water 0.1% PO008
- CGR-ES-064 · Menthol spirit 5% w/v PO012
- CGR-ES-065 · Calamine lotion PO014
- CGR-ES-066 · Aqueous zinc paste PO017
- CGR-ES-067 · Lassar paste without salicylic acid PO018
- CGR-ES-068 · Mentholated zinc oxide powder PO020
- CGR-ES-069 · Menthol petrolatum 1% PO031
- CGR-ES-070 · Hydrocortisone acetate 0.5%, phenol 0.5%, menthol 0.2% and zinc oxide 2% cream
- CGR-ES-071 · Salicylic acid 5% and triamcinolone acetonide 0.1% cream
- CGR-ES-072 · Silver nitrate cutaneous solution 2% w/w
- CGR-ES-073 · Tannic acid alcoholic solution 10% w/v
- CGR-ES-074 · Menthol 10% and methyl salicylate 15% analgesic ointment
- CGR-ES-075 · Copper sulfate pentahydrate cutaneous solution 0.1% w/v
- CGR-ES-076 · Rosemary essential oil alcoholic solution 5% v/v
- CGR-ES-077 · Peru balsam ointment 6% w/w
- CGR-ES-078 · Camphor spirit 10% w/v
- CGR-ES-079 · Menthol 1% and thymol 1% rubefacient in rosemary spirit
- CGR-JP-005 · White Ointment JP
- CGR-JP-006 · Zinc Oxide Ointment JP 20% w/w
- CGR-JP-007 · Ethanol for Disinfection JP
- CGR-JP-008 · Iodine Tincture JP 6% with potassium iodide 4%
- CGR-JP-009 · Zinc Oxide Starch Powder JP 50% w/w
- CGR-JP-010 · Sulfur and Camphor Lotion JP
- CGR-JP-011 · Salicylic Acid Spirit JP 3% w/v
- CGR-JP-012 · Salicylated Alum Powder JP 3% w/w
- CGR-JP-013 · Hydrocortisone Acetate 0.5% and Diphenhydramine Base 0.5% Ointment JP
- CGR-JP-014 · Acrinol Hydrate 1% and Zinc Oxide Ointment JP
- CGR-JP-015 · Zinc Oxide Oil JP 50% w/w — Olive Oil JP variant
- CGR-JP-016 · Acrinol Hydrate 1% and Zinc Oxide Oil JP
- CGR-FR-035 · Patent Blue V coloured alcohol 60% v/v
- CGR-FR-036 · Silver nitrate sticks 633 mg/g
- CGR-FR-037 · Colloidal silver ointment
- CGR-FR-038 · Hawthorn tincture
- CGR-FR-039 · Witch-hazel tincture
- CGR-FR-040 · Hawthorn fluid extract
- CGR-FR-041 · Witch-hazel fluid extract
- CGR-FR-042 · Passionflower fluid extract
- CGR-ES-080 · Salicylic acid 6% and triamcinolone acetonide 0.1% gel
- CGR-ES-081 · Salicylic acid and lactic acid collodion
- CGR-ES-082 · Erythromycin 2% cream
- CGR-ES-083 · Methadone hydrochloride 10 mg/mL (1% w/v) aqueous oral solution
- CGR-ES-084 · Morphine hydrochloride 10 mg/mL (1% w/v) oral solution with simple syrup
- CGR-ES-085 · Lidocaine HCl 1% compound buccal suspension
- CGR-ES-086 · Phenobarbital 10 mg/mL expressed as base, from sodium salt — oral solution
- CGR-ES-087 · Chloral hydrate 5% w/v enema (50 mg/mL)
- CGR-ES-088 · Chloral hydrate 10% w/v oral syrup with preservative (100 mg/mL)
- CGR-ES-089 · Gomenol 2% w/w cutaneous oil solution
- CGR-ES-090 · Tannic acid cutaneous solution in ethanol–glycerol, 5 g/50 mL/50 mL formula
- CGR-ES-091 · Boric acid 3% w/v aqueous cutaneous solution
- CGR-ES-092 · Saturated boric acid otic solution in ethanol 70% — 5 g/100 mL charge
- CGR-ES-093 · Iodine 2% w/v alcoholic solution with potassium iodide 2.5% w/v
- CGR-ES-094 · Glycerol–wheat starch cutaneous gel, 90/10/10 g formula
- CGR-ES-095 · Potassium permanganate 0.01% w/v (1 in 10,000) cutaneous solution
- CGR-ES-096 · Racemic camphor 10% w/w ointment with white beeswax 8% w/w
- CGR-ES-097 · Povidone-iodine 10% w/v in buffered vehicle, cutaneous solution
- CGR-ES-098 · Borax 1% w/v mouth-rinse solution
- CGR-ES-099 · Racemic menthol 1% w/w in talc
- CGR-ES-100 · Boric acid 10% w/w in white soft paraffin
- CGR-ES-101 · Salicylic acid 5% w/w ointment with 3% liquid paraffin
- CGR-ES-102 · Alibour water with copper sulfate 0.1%, zinc sulfate 0.4% and camphor 0.1% w/v
- CGR-ES-103 · Glycerinated alcohol —50 g glycerol plus 50 mL hydroalcoholic vehicle 2
- CGR-ES-104 · Methyl salicylate 1%, menthol 3% and camphor 2.5% w/w analgesic cream
- CGR-ES-105 · Boric acid/tannic acid foot powder with thymol
- CGR-ES-106 · Barbados aloes dried leaf juice 50 mg — hard capsules
- CGR-ES-107 · Cascara bark 300 mg — hard capsules
- CGR-ES-108 · Frangula bark 300 mg — hard capsules
- CGR-ES-109 · Ispaghula husk with fructose/maltodextrin — powder for oral suspension
- CGR-ES-110 · Standardised frangula bark dry extract 50 mg — hard capsules
- CGR-ES-111 · Standardised senna leaf dry extract 100 mg — hard capsules
- CGR-ES-112 · Fennel fruit 250 mg — hard capsules
- CGR-ES-113 · Bearberry leaf 400 mg — herbal powder hard capsules
- CGR-ES-114 · Orthosiphon leaf 400 mg — herbal powder hard capsules
- CGR-ES-115 · Rosemary leaf 250 mg — herbal powder hard capsules
- CGR-ES-116 · Senna leaf 300 mg — hard capsules
- CGR-ES-117 · Garlic bulb powder 500 mg — herbal powder hard capsules
- CGR-ES-118 · Devil’s claw root 500 mg — herbal powder hard capsules
- CGR-ES-119 · Valerian root 500 mg — herbal powder hard capsules
- CGR-ES-120 · Psyllium seed powder with fructose/maltodextrin — powder for oral suspension
Sops · 36
- SOP-001 · Document control and local adoption
- SOP-002 · Request and risk assessment
- SOP-003 · Training, hygiene and clothing
- SOP-004 · Suppliers, receipt and raw materials
- SOP-005 · Facility, cleaning and line clearance
- SOP-006 · Equipment, calibration and maintenance
- SOP-007 · Calculations and weighing
- SOP-008 · Master formulation and batch record
- SOP-009 · Oral solutions, syrups and suspensions
- SOP-010 · Semisolids, emulsions and gels
- SOP-011 · Powders and hard capsules
- SOP-012 · Packaging, labelling and handover
- SOP-013 · Sampling, QC and release
- SOP-014 · Stability and BUD justification
- SOP-015 · Deviations, CAPA, complaints and recall
- SOP-016 · External testing, data and change control
- SOP-017 · Water activity measurement
- SOP-018 · Hazardous materials and volatile solvents
- SOP-019 · Microbiological quality and preservative effectiveness
- SOP-020 · Stability-study applicability and BUD extension
- SOP-021 · Storage and transport temperature
- SOP-022 · Cleaning verification for actives and allergens
- SOP-023 · Clinical excipient and dose review
- SOP-024 · Sources versions and scientific publication
- OIT-001 · Allergist interface and order verification
- OIT-002 · Allergen identity and protein basis
- OIT-003 · Allergen segregation and staff protection
- OIT-004 · Controlled processing and protein recovery
- OIT-005 · Uniformity, redispersibility and dosing device
- OIT-006 · Microbiology, packaging and stability
- OIT-007 · Allergen label and safe handover
- OIT-008 · Incident, recall and reassessment
- SOP-025 · Water quality, receipt and use
- SOP-026 · Self-audit and quality-system review
- SOP-027 · Suitability for an enteral feeding tube
- SOP-036 · Water activity, stability evidence and BUD assignment policy
Forms · 22
- F-001 · Local adoption and risk assessment
- F-002 · Master formulation record
- F-003 · Blank batch record
- F-004 · Equipment and cleaning record
- F-005 · Sampling and QC results
- F-006 · Stability and BUD rationale
- F-007 · Deviation, CAPA and recall
- F-008 · Allergen raw-material dossier
- F-009 · Allergen process verification
- F-010 · Allergen traceability and handover
- F-011 · Training and competency
- F-012 · Water activity evidence
- F-013 · Stability applicability and study plan
- F-014 · Temperature and excursions
- F-015 · Quantitative cleaning verification
- F-016 · Source and publication rights
- F-017 · Raw-material receipt and release
- F-018 · Supply and traceability
- F-019 · Water quality and use record
- F-020 · Self-audit and quality review
- F-021 · Clinical excipient exposure and device/route suitability
- F-022 · Evidence and closure-criteria record
Publications · 17
- PUB-001 · From compounding to formulation design
- PUB-002 · Ten potential compounding failure mechanisms
- PUB-003 · Compounding documentation with controlled records
- PUB-004 · From an unmet need to a development plan
- PUB-005 · Ingredient and finished-preparation compatibility
- PUB-006 · Stability rationale in pharmacy compounding
- PUB-007 · Choosing a dosage form
- PUB-008 · Lessons from compounding for product development
- PUB-009 · Assessing a case as a research opportunity
- PUB-010 · Written procedures for nonsterile compounding
- PUB-011 · Compounding records and traceability
- PUB-012 · Compounding service in dermatological care
- PUB-013 · Practical BUD selection and documentation
- PUB-014 · Water activity and interpretation
- PUB-015 · Allergen preparations and quality evidence
- PUB-016 · Clinical excipient assessment and daily exposure
- PUB-017 · Analytical testing and actual delivered dose
Allergens · 5
- ALG-001 · Pistachio — syrup-matrix development dossier
- ALG-002 · Peanut — suspension-development dossier
- ALG-003 · Cashew and its relationship to pistachio
- ALG-004 · Milk allergy and preparation evidence
- ALG-005 · Egg allergy and preparation evidence